Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 15, 2025Global Journal For Research Analysis

Antimicrobial Susceptibility Pattern of Pseudomonas Aeruginosa Species Isolated From Various Clinical Samples in Tertiary Care Center Jhalawar

View Full Paper
Ask AI
Bookmark
Share

Authors

SBSonam BansalSHShilpi HoraPGParul Gupta

Discussion

Loading...

Member takes

Overview

Retrospective analysis reveals high resistance rates in Pseudomonas aeruginosa from clinical samples, suggesting urgent need for monitoring.

Key Points

  • The prevalence of P. aeruginosa was found to be 5.06%, highlighting its significant presence in clinical samples.
  • Meropenem and Imipenem showed the highest sensitivity rates at 92.91% and 92.6%, respectively, indicating effectiveness against this pathogen.
  • Laboratory identification and susceptibility testing were conducted using established methods, ensuring reliability of findings.
  • The study emphasizes the urgent need for effective antibiotic stewardship to combat rising multidrug resistance.

Cite This Study

Bansal et al. (2025) studied this question.

synapsesocial.com/papers/68af2b63cf1dd9ea359e4949https://doi.org/10.36106/gjra/1606496
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Trend of Pseudomonas aeruginosa antimicrobial susceptibility pattern from a rural North Indian healthcare setting2025 · 2 citations
  2. 2A Longitudinal Study on Antimicrobial Resistance Dynamics in Pseudomonas aeruginosa at a Government Superspeciality Hospital2025
  3. 3Incidence and Multidrug Resistance of Pseudomonas Aeruginosa Isolated from Clinical Samples in Diyala2025 · 2 citations
  4. 4Molecular Identification and Antibiotic Resistance Profile of Some Pseudomonas aeruginosa Clinical Isolates2025 · 1 citations
  5. 5ANTIMICROBIAL RESISTANCE PATTERNS AND PHENOTYPIC CARBAPENEMASE DETECTION IN CLINICAL PSEUDOMONAS AERUGINOSA ISOLATES2025